missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Mouse gp130 Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 468-MG-100
Additional Details : Weight : 0.00970kg
Description
The Recombinant Mouse gp130 Fc Chimera Protein is derived from NS0. The Recombinant Mouse gp130 Fc Chimera Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 115 kDa, reducing conditions | |
| 100μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| 16195 | |
| gp130 Fc Chimera | |
| Mouse myeloma cell line,NS0-derived mouse gp130 protein, (N-terminus) Mouse gp130 (Gln23-Glu617) Accession &Num; Q6PDI9 DIEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus) | |
| Disulfide-linked homodimer | |
| Recombinant |